1.89
Finanzdaten der In 8 Bio Inc-Aktie (INAB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
5.61%
0.113
|
0.107 | 0.11 | 0.064 | 0.023 |
|
|
23.73%
3.967
|
5.201 | 5.66 | 6.224 | 7.109 |
| Benefits Costs and Expenses |
23.73%
3.967
|
5.201 | 5.66 | 11.78 | 7.109 |
| Costs And Expenses |
23.73%
3.967
|
5.201 | 5.66 | 6.224 | 7.109 |
| Operating Income/Loss |
24.34%
-3.854
|
-5.094 | -5.55 | -6.16 | -7.086 |
| Income/Loss From Continuing Operations Before Tax |
24.34%
-3.854
|
-5.094 | -5.55 | -11.71 | -7.086 |
| Income/Loss From Continuing Operations After Tax |
24.34%
-3.854
|
-5.094 | -5.55 | -6.16 | -7.086 |
|
|
24.34%
-3.854
|
-5.094 | -5.55 | -6.16 | -7.086 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.16%
4.5377
|
4.1192 | 83.48 | 7.8564 | 47.32 |
| Diluted Average Shares |
10.16%
4.5377
|
4.1192 | 83.48 | 7.8564 | 47.32 |
| Basic Earnings Per Share |
31.45%
-0.85
|
-1.24 | -0.07 | -0.04 | -0.15 |
| Diluted Earnings Per Share |
31.45%
-0.85
|
-1.24 | -0.07 | -0.04 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):